Item Type | Name |
Academic Article
|
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.
|
Academic Article
|
Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
|
Academic Article
|
Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media.
|
Academic Article
|
Persistent pulmonary hypertension of the newborn.
|
Academic Article
|
Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension.
|
Academic Article
|
Diethylcarbamazine inhibits acute and chronic hypoxic pulmonary hypertension in awake rats.
|
Academic Article
|
Persistence of the fetal pattern of tropoelastin gene expression in severe neonatal bovine pulmonary hypertension.
|
Academic Article
|
Progressive loss of vasodilator responsive component of pulmonary hypertension in neonatal calves exposed to 4,570 m.
|
Academic Article
|
Alterations in extracellular matrix protein expression in neonatal pulmonary hypertension: implications for vascular function.
|
Academic Article
|
Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension.
|
Academic Article
|
Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.
|
Academic Article
|
Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
|
Academic Article
|
Smooth muscle cell heterogeneity: role of specific smooth muscle cell subpopulations in pulmonary vascular disease.
|
Academic Article
|
Treatments for severe pulmonary hypertension.
|
Academic Article
|
Mechanisms of structural remodeling in chronic pulmonary hypertension.
|
Academic Article
|
Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension.
|
Academic Article
|
Transforming growth factor-beta 1 is decreased in remodeling hypertensive bovine pulmonary arteries.
|
Academic Article
|
Myocyte cytoskeletal disorganization and right heart failure in hypoxia-induced neonatal pulmonary hypertension.
|
Academic Article
|
Unilateral pulmonary hypertension as a result of chronic high flow to one lung.
|
Academic Article
|
Bromodeoxyuridine labeling and DNA content of pulmonary arterial medial cells from hypoxia-exposed and nonexposed healthy calves.
|
Academic Article
|
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.
|
Academic Article
|
Lung endothelial cell proliferation in normal and pulmonary hypertensive neonatal calves.
|
Academic Article
|
Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension.
|
Academic Article
|
Hypoxia, leukocytes, and the pulmonary circulation.
|
Academic Article
|
Neonatal calves develop airflow limitation due to chronic hypobaric hypoxia.
|
Academic Article
|
Changes in lung eicosanoid content during normal and abnormal transition in perinatal lambs.
|
Academic Article
|
Determination of transforming growth factor-beta mRNA levels in pulmonary arteries from normal and hypoxic calves.
|
Academic Article
|
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.
|
Academic Article
|
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.
|
Academic Article
|
Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling.
|
Academic Article
|
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.
|
Academic Article
|
Inflammation, growth factors, and pulmonary vascular remodeling.
|
Academic Article
|
Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment.
|
Academic Article
|
Cellular and molecular basis of pulmonary arterial hypertension.
|
Academic Article
|
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.
|
Academic Article
|
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.
|
Academic Article
|
Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension.
|
Academic Article
|
Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.
|
Academic Article
|
Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension.
|
Academic Article
|
Cell-based therapies in pulmonary hypertension: who, what, and when?
|
Academic Article
|
Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.
|
Academic Article
|
Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells.
|
Academic Article
|
Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.
|
Academic Article
|
Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.
|
Academic Article
|
Impact of residual stretch and remodeling on collagen engagement in healthy and pulmonary hypertensive calf pulmonary arteries at physiological pressures.
|
Academic Article
|
Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.
|
Academic Article
|
Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia.
|
Academic Article
|
Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.
|
Academic Article
|
Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGF? receptor-JNK1 signalling.
|
Academic Article
|
MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
|
Academic Article
|
The renin-angiotensin system in pulmonary hypertension.
|
Academic Article
|
Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension.
|
Academic Article
|
Mechanics and function of the pulmonary vasculature: implications for pulmonary vascular disease and right ventricular function.
|
Academic Article
|
Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension.
|
Academic Article
|
Abnormal alveolar cells in monocrotaline induced pulmonary hypertension.
|
Academic Article
|
Cellular and molecular pathobiology of pulmonary arterial hypertension.
|
Academic Article
|
Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension.
|
Academic Article
|
Alteration of the pulsatile load in the high-altitude calf model of pulmonary hypertension.
|
Academic Article
|
Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes.
|
Academic Article
|
New hope for the treatment of pulmonary hypertension: novel approaches to a complex disease.
|
Academic Article
|
Pulmonary vascular impedance and wave reflections in the hypoxic calf.
|
Academic Article
|
Insulin-like growth factor I and pulmonary hypertension induced by continuous air embolization in sheep.
|
Academic Article
|
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.
|
Academic Article
|
Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?
|
Academic Article
|
Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.
|
Academic Article
|
Effects of pathological flow on pulmonary artery endothelial production of vasoactive mediators and growth factors.
|
Academic Article
|
In vivo measurement of proximal pulmonary artery elastic modulus in the neonatal calf model of pulmonary hypertension: development and ex vivo validation.
|
Academic Article
|
Emerging therapies for the treatment of pulmonary hypertension.
|
Academic Article
|
Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.
|
Academic Article
|
Fibrocytes: potential new therapeutic targets for pulmonary hypertension?
|
Academic Article
|
Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization.
|
Academic Article
|
Linked opening angle and histological and mechanical aspects of the proximal pulmonary arteries of healthy and pulmonary hypertensive rats and calves.
|
Academic Article
|
Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.
|
Academic Article
|
Response of lobar vessels to hypoxic pulmonary hypertension.
|
Academic Article
|
Response to letter regarding article, ?histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid?.
|
Academic Article
|
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m.
|
Academic Article
|
Physiologic and molecular consequences of endothelial Bmpr2 mutation.
|
Academic Article
|
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension.
|
Academic Article
|
Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.
|
Academic Article
|
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
Academic Article
|
Activation of the unfolded protein response is associated with pulmonary hypertension.
|
Academic Article
|
Mechanics and mechanisms of pulmonary hypertension: An introduction to the 55(th) annual Thomas L. Petty Aspen Lung Conference.
|
Academic Article
|
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.
|
Academic Article
|
Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell.
|
Academic Article
|
[Inhibition of hypoxic pulmonary vasoconstriction by leukotriene blockade].
|
Concept
|
Hypertension, Pulmonary
|
Academic Article
|
Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies.
|
Academic Article
|
Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011.
|
Academic Article
|
MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts.
|
Academic Article
|
Relevant issues in the pathology and pathobiology of pulmonary hypertension.
|
Academic Article
|
An official American Thoracic Society Statement: pulmonary hypertension phenotypes.
|
Academic Article
|
High proliferative potential endothelial colony-forming cells contribute to hypoxia-induced pulmonary artery vasa vasorum neovascularization.
|
Academic Article
|
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension.
|
Academic Article
|
Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
|
Academic Article
|
Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-?B pathway.
|
Academic Article
|
Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.
|
Academic Article
|
Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction.
|
Academic Article
|
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
|
Academic Article
|
Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).
|
Academic Article
|
[Relevant issues in the pathology and pathobiology of pulmonary hypertension].
|
Academic Article
|
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
|
Academic Article
|
Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
|
Academic Article
|
Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension.
|
Academic Article
|
Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series).
|
Academic Article
|
The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia.
|
Academic Article
|
MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
|
Academic Article
|
The altitude at which a calf is born and raised influences the rate at which mean pulmonary arterial pressure increases with age.
|
Academic Article
|
Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.
|
Academic Article
|
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
|
Academic Article
|
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
|
Academic Article
|
Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.
|
Academic Article
|
Right Ventricular Longitudinal Strain Is Depressed in a Bovine Model of Pulmonary Hypertension.
|
Academic Article
|
Stiffening of the Extrapulmonary Arteries From Rats in Chronic Hypoxic Pulmonary Hypertension.
|
Academic Article
|
Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.
|
Academic Article
|
Pulmonary Veno-occlusive Disease and Pulmonary Hypertension in Dogs: Striking Similarities to the Human Condition.
|
Academic Article
|
Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.
|
Academic Article
|
Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.
|
Academic Article
|
Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
|
Academic Article
|
Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.
|
Academic Article
|
Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).
|
Academic Article
|
Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation.
|
Academic Article
|
Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
|
Academic Article
|
Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
|
Grant
|
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
|
Grant
|
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment
|
Grant
|
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension
|
Grant
|
Adaptation to Hypoxia
|
Grant
|
LUNG LIPIDS IN NEONATAL PULMONARY HYPERTENSIVE DISEASES
|
Academic Article
|
A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
|
Academic Article
|
TGF-? activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
|
Academic Article
|
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.
|
Academic Article
|
Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
|
Academic Article
|
Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.
|
Academic Article
|
Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
|
Academic Article
|
Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations.
|
Academic Article
|
Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
|
Academic Article
|
A Twist on Pulmonary Vascular Remodeling: Endothelial to Mesenchymal Transition?
|
Academic Article
|
How Many FOXs Are There on The Road to Pulmonary Hypertension?
|
Academic Article
|
Peroxisome Proliferator-activated Receptor ? and Mitochondria: Drivers or Passengers on the Road to Pulmonary Hypertension?
|
Academic Article
|
JNK2 regulates vascular remodeling in pulmonary hypertension.
|
Academic Article
|
Repurposing rosiglitazone, a PPAR-? agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
|
Academic Article
|
Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.
|
Academic Article
|
Urocortin 2: will a drug targeting both the vasculature and the right ventricle be the future of pulmonary hypertension therapy?
|
Academic Article
|
Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension.
|
Academic Article
|
Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension.
|
Academic Article
|
Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention.
|
Academic Article
|
Cardiopulmonary remodeling in fattened beef cattle: a naturally occurring large animal model of obesity-associated pulmonary hypertension with left heart disease.
|
Academic Article
|
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
|
Academic Article
|
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
|
Academic Article
|
Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases.
|
Academic Article
|
Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature.
|
Concept
|
Familial Primary Pulmonary Hypertension
|
Academic Article
|
CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil.
|
Academic Article
|
The right ventricular fibroblast secretome drives cardiomyocyte dedifferentiation.
|
Academic Article
|
A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention.
|
Academic Article
|
An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.
|
Academic Article
|
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
|
Academic Article
|
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
|
Academic Article
|
Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension.
|
Academic Article
|
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
|
Academic Article
|
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy.
|
Academic Article
|
Pluripotent hematopoietic stem cells augment a-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.
|
Academic Article
|
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment.
|
Academic Article
|
c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.
|
Academic Article
|
Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation.
|
Academic Article
|
Publisher Correction: Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment.
|
Academic Article
|
Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.
|
Academic Article
|
RNA-Binding Proteins in Pulmonary Hypertension.
|
Academic Article
|
Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
|
Academic Article
|
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application.
|
Academic Article
|
17?-Estradiol and estrogen receptor a protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.
|
Academic Article
|
Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.
|
Academic Article
|
Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension.
|
Academic Article
|
Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension.
|
Academic Article
|
Hemodynamically Unloading the Distal Pulmonary Circulation in Pulmonary Hypertension: A Modeling Study.
|
Academic Article
|
Endothelial cell PHD2-HIF1a-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension.
|
Academic Article
|
The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension.
|
Academic Article
|
Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
|
Academic Article
|
Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension.
|
Academic Article
|
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
|
Academic Article
|
Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
|
Academic Article
|
Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.
|
Academic Article
|
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.
|
Academic Article
|
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
|
Academic Article
|
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension.
|
Academic Article
|
The Effect of Hypoxia-inducible Factor Inhibition on the Phenotype of Fibroblasts in Human and Bovine Pulmonary Hypertension.
|
Academic Article
|
Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model.
|
Academic Article
|
Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension.
|
Academic Article
|
Characterizing the Spatiotemporal Transcriptomic Response of the Right Ventricle to Acute Pressure Overload.
|
Academic Article
|
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
|
Academic Article
|
Microenvironmental regulation of T-cells in pulmonary hypertension.
|